Proteinase k resistant surface protein of neisseria meningitidis
CA 2215161 C · Owner: Rioux, Clement · Inventors: Martin, Denis; Brodeur, Bernard; Hamel, Josee
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A highly conserved, immunologically accessible antigen at the surface of Neisseria meningitidis organisms. Immunotherapeutic prophylactic and , diagnostic compositions and methods useful in the treatment prevention and , diagnosis of Neisseria meningitidis diseases. A proteinase K resistant Neisseria meningitidis surface protein having an apparent molecular weight of 22 kDa, the corresponding nucleotide and derived amino acid sequences (SEQ ID NO:1, NO:3, NO:5, and NO:7: SEQ ID NO:2 NO:4, NO:6, and NO:8), recombinant , DNA methods for the production of the Neisseria meningitidis 22 kDa surface protein, and antibodies that bind to the Neisseria meningitidis 22 kDa surface protein.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 15, 1996 and granted October 30, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 15, 2016.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 15, 2018.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.